Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Exelixis Cash on Hand 2011-2025 | EXEL

Exelixis cash on hand from 2011 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  • Exelixis cash on hand for the quarter ending September 30, 2025 was $0.989B, a 16.87% decline year-over-year.
  • Exelixis cash on hand for 2024 was $1.111B, a 11.65% increase from 2023.
  • Exelixis cash on hand for 2023 was $0.995B, a 23.93% decline from 2022.
  • Exelixis cash on hand for 2022 was $1.308B, a 10.81% decline from 2021.
Exelixis Annual Cash on Hand
(Millions of US $)
2024 $1,111
2023 $995
2022 $1,308
2021 $1,467
2020 $1,207
2019 $852
2018 $693
2017 $388
2016 $420
2015 $167
2014 $156
2013 $255
2012 $424
2011 $194
2010 $163
Exelixis Quarterly Cash on Hand
(Millions of US $)
2025-09-30 $989
2025-06-30 $791
2025-03-31 $1,031
2024-12-31 $1,111
2024-09-30 $1,189
2024-06-30 $1,002
2024-03-31 $963
2023-12-31 $995
2023-09-30 $1,103
2023-06-30 $1,267
2023-03-31 $1,313
2022-12-31 $1,308
2022-09-30 $1,547
2022-06-30 $1,535
2022-03-31 $1,570
2021-12-31 $1,467
2021-09-30 $1,403
2021-06-30 $1,347
2021-03-31 $1,185
2020-12-31 $1,207
2020-09-30 $1,188
2020-06-30 $1,213
2020-03-31 $954
2019-12-31 $852
2019-09-30 $761
2019-06-30 $822
2019-03-31 $800
2018-12-31 $693
2018-09-30 $635
2018-06-30 $500
2018-03-31 $427
2017-12-31 $388
2017-09-30 $367
2017-06-30 $349
2017-03-31 $424
2016-12-31 $420
2016-09-30 $320
2016-06-30 $328
2016-03-31 $322
2015-12-31 $167
2015-09-30 $198
2015-06-30 $83
2015-03-31 $113
2014-12-31 $156
2014-09-30 $204
2014-06-30 $246
2014-03-31 $286
2013-12-31 $255
2013-09-30 $291
2013-06-30 $364
2013-03-31 $369
2012-12-31 $424
2012-09-30 $485
2012-06-30 $207
2012-03-31 $243
2011-12-31 $194
2011-09-30 $223
2011-06-30 $263
2011-03-31 $302
2010-12-31 $163
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $10.939B $2.169B
Exelixis, Inc. is an oncology-focused biotechnology company, which primarily focuses on the discovery, development and commercialization of new drugs for the treatment of difficult-to-treat cancers. The company has four approved drugs in its portfolio. Of these, two are derived from cabozantinib, the company's flagship molecule, which is an inhibitor of multiple tyrosine kinases, including MET, AXL, VEGF receptors and RET.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $259.805B 18.33
Amgen (AMGN) United States $169.939B 14.43
Gilead Sciences (GILD) United States $153.116B 15.07
Vertex Pharmaceuticals (VRTX) United States $105.610B 27.19
GSK (GSK) United Kingdom $95.740B 10.63
Bristol Myers Squibb (BMY) United States $94.927B 7.11
Regeneron Pharmaceuticals (REGN) United States $68.560B 17.64
Alnylam Pharmaceuticals (ALNY) United States $58.195B 1915.17
CSL (CSLLY) Australia $56.210B 0.00
Argenex SE (ARGX) Netherlands $52.396B 65.06
Insmed (INSM) United States $39.601B 0.00
Novozymes (NVZMY) Denmark $29.971B 0.00
Royalty Pharma (RPRX) United States $23.782B 9.02
BioNTech SE (BNTX) Germany $23.273B 0.00
Biogen (BIIB) United States $22.994B 9.36
Incyte (INCY) United States $20.653B 19.77
Genmab (GNMSF) Denmark $18.831B 13.81
Genmab (GMAB) Denmark $18.517B 13.93
Illumina (ILMN) United States $18.506B 27.78
Roivant Sciences (ROIV) United Kingdom $14.047B 0.00
Exact Sciences (EXAS) United States $12.736B 353.79
Swedish Orphan Biovitrum (BIOVF) Sweden $12.417B 23.10
Ascendis Pharma (ASND) Denmark $12.295B 0.00
Guardant Health (GH) United States $12.131B 0.00
Revolution Medicines (RVMD) United States $11.866B 0.00
Avidity Biosciences (RNA) United States $10.181B 0.00
BioMarin Pharmaceutical (BMRN) United States $9.959B 18.06
QIAGEN (QGEN) Netherlands $9.572B 18.17
Moderna (MRNA) United States $9.503B 0.00
Bio-Techne Corp (TECH) United States $9.065B 33.83
Metsera (MTSR) United States $8.587B 0.00
Bio-Rad Laboratories (BIO.B) United States $8.311B 29.62
Repligen (RGEN) United States $8.161B 87.34
Jazz Pharmaceuticals (JAZZ) Ireland $8.146B 31.76
Abivax SA (ABVX) France $8.086B 0.00
Halozyme Therapeutics (HALO) United States $8.042B 12.85
Cytokinetics (CYTK) United States $7.373B 0.00
Merus (MRUS) Netherlands $7.217B 0.00
Axsome Therapeutics (AXSM) United States $7.028B 0.00
Nuvalent (NUVL) United States $6.913B 0.00
Rhythm Pharmaceuticals (RYTM) United States $6.573B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $6.557B 0.00
Legend Biotech (LEGN) United States $5.975B 0.00
PTC Therapeutics (PTCT) United States $5.828B 7.92
Krystal Biotech (KRYS) United States $5.799B 29.98
Arrowhead Pharmaceuticals (ARWR) United States $5.475B 0.00
Vaxcyte (PCVX) United States $5.460B 0.00
TG Therapeutics (TGTX) United States $5.280B 11.96
Alkermes (ALKS) Ireland $5.231B 15.38
CRISPR Therapeutics AG (CRSP) Switzerland $5.149B 0.00
Arcellx (ACLX) United States $5.100B 0.00
Protagonist Therapeutics (PTGX) United States $4.963B 128.68
Zealand Pharma (ZLDPF) Denmark $4.688B 4.63
Kymera Therapeutics (KYMR) United States $4.389B 0.00
Akero Therapeutics (AKRO) United States $4.312B 0.00
Praxis Precision Medicines (PRAX) United States $4.310B 0.00
Viking Therapeutics (VKTX) United States $4.213B 0.00
Immunovant (IMVT) United States $4.126B 0.00
Ligand Pharmaceuticals (LGND) United States $4.080B 100.59
ACADIA Pharmaceuticals (ACAD) United States $3.653B 30.93
Belite Bio (BLTE) United States $3.557B 0.00
Mirum Pharmaceuticals (MIRM) United States $3.480B 0.00
ADMA Biologics Inc (ADMA) United States $3.348B 23.78
Telix Pharmaceuticals (TLX) Australia $3.344B 0.00
Celcuity (CELC) United States $3.148B 0.00
Arcutis Biotherapeutics (ARQT) United States $3.075B 0.00
CG Oncology (CGON) United States $3.026B 0.00
Disc Medicine (IRON) United States $3.025B 0.00
Ascentage Pharma Group - (AAPG) China $3.020B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.986B 0.00
Travere Therapeutics (TVTX) United States $2.979B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.960B 0.00
Tarsus Pharmaceuticals (TARS) United States $2.890B 0.00
GRAIL (GRAL) United States $2.886B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $2.863B 85.84
Jyong Biotech (MENS) Taiwan $2.845B 0.00
Scholar Rock Holding (SRRK) United States $2.768B 0.00
Amicus Therapeutics (FOLD) United States $2.746B 222.50
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.695B 0.00
Viridian Therapeutics (VRDN) United States $2.625B 0.00
IDEAYA Biosciences (IDYA) United States $2.617B 0.00
Zai Lab (ZLAB) China $2.587B 0.00
Apogee Therapeutics (APGE) United States $2.536B 0.00
Cidara Therapeutics (CDTX) United States $2.501B 0.00
Apellis Pharmaceuticals (APLS) United States $2.494B 63.58
Mineralys Therapeutics (MLYS) United States $2.454B 0.00
Adaptive Biotechnologies (ADPT) United States $2.375B 0.00
Anbio Biotechnology (NNNN) Germany $2.354B 0.00
Agios Pharmaceuticals (AGIO) United States $2.351B 0.00
Beam Therapeutics (BEAM) United States $2.349B 0.00
Bavarian Nordic (BVNRY) Denmark $2.270B 10.98
Liquidia (LQDA) United States $2.227B 0.00
Arcus Biosciences (RCUS) United States $2.112B 0.00
Denali Therapeutics (DNLI) United States $2.107B 0.00
ImmunityBio (IBRX) United States $2.088B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.006B 0.00
ANI Pharmaceuticals (ANIP) United States $1.958B 17.55
Vericel (VCEL) United States $1.955B 161.46
Structure Therapeutics (GPCR) United States $1.928B 0.00
Mesoblast (MESO) Australia $1.915B 0.00
Twist Bioscience (TWST) United States $1.849B 0.00
Certara (CERT) United States $1.810B 33.15
Edgewise Therapeutics (EWTX) United States $1.800B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.782B 9.73
MannKind (MNKD) United States $1.750B 57.00
Sarepta Therapeutics (SRPT) United States $1.724B 0.00
Janux Therapeutics (JANX) United States $1.722B 0.00
Nuvation Bio (NUVB) United States $1.718B 0.00
Cogent Biosciences (COGT) United States $1.676B 0.00
Vera Therapeutics (VERA) United States $1.610B 0.00
Terns Pharmaceuticals (TERN) United States $1.597B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.592B 0.00
Celldex Therapeutics (CLDX) United States $1.545B 0.00
Sionna Therapeutics (SION) United States $1.535B 0.00
Alvotech (ALVO) Luxembourg $1.526B 11.50
UniQure (QURE) Netherlands $1.509B 0.00
Zenas BioPharma (ZBIO) United States $1.367B 0.00
AbCellera Biologics (ABCL) Canada $1.354B 0.00
Spyre Therapeutics (SYRE) United States $1.352B 0.00
Immunome (IMNM) United States $1.349B 0.00
NeoGenomics (NEO) United States $1.346B 0.00
Zymeworks (ZYME) United States $1.345B 0.00
Trevi Therapeutics (TRVI) United States $1.341B 0.00
Intellia Therapeutics (NTLA) United States $1.323B 0.00
Maze Therapeutics (MAZE) United States $1.299B 0.00
Dynavax Technologies (DVAX) United States $1.291B 37.90
Stoke Therapeutics (STOK) United States $1.283B 33.54
Upstream Bio (UPB) United States $1.279B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.277B 0.00
NovoCure (NVCR) Jersey $1.262B 0.00
WAVE Life Sciences (WVE) Singapore $1.254B 0.00
Novavax (NVAX) United States $1.233B 3.14
Oric Pharmaceuticals (ORIC) United States $1.219B 0.00
CureVac (CVAC) Germany $1.178B 5.47
Inhibrx Biosciences (INBX) United States $1.173B 0.00
Dianthus Therapeutics (DNTH) United States $1.173B 0.00
Precigen (PGEN) United States $1.168B 0.00
Pharvaris (PHVS) Netherlands $1.140B 0.00
Immatics (IMTX) Germany $1.122B 0.00
Urogen Pharma (URGN) United States $1.089B 0.00
MiMedx (MDXG) United States $1.086B 19.29
Tango Therapeutics (TNGX) United States $1.078B 0.00
AnaptysBio (ANAB) United States $1.058B 0.00
Pharming Group (PHGUF) Netherlands $1.027B 153.00
Fortrea Holdings (FTRE) United States $1.018B 21.61
Oculis Holding AG (OCS) Switzerland $1.017B 0.00
Pharming Group (PHAR) Netherlands $1.007B 0.00
Castle Biosciences (CSTL) United States $0.979B 134.20
BridgeBio Oncology Therapeutics (BBOT) United States $0.970B 0.00
Sana Biotechnology (SANA) United States $0.963B 0.00
Nurix Therapeutics (NRIX) United States $0.963B 0.00
Pacira BioSciences (PCRX) United States $0.948B 10.39
Nanobiotix S.A - (NBTX) France $0.943B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.928B 0.00
Rapport Therapeutics (RAPP) United States $0.926B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.923B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.922B 0.00
Biohaven (BHVN) United States $0.902B 0.00
BGM Group (BGM) China $0.894B 0.00
Kodiak Sciences (KOD) United States $0.893B 0.00
Kura Oncology (KURA) United States $0.884B 0.00
Rezolute (RZLT) United States $0.872B 0.00
Palvella Therapeutics (PVLA) United States $0.870B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.863B 0.00
Arbutus Biopharma (ABUS) United States $0.851B 0.00
CorMedix Inc (CRMD) United States $0.845B 14.37
Septerna (SEPN) United States $0.838B 0.00
Iovance Biotherapeutics (IOVA) United States $0.836B 0.00
MBX Biosciences (MBX) United States $0.831B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.803B 40.66
Bicara Therapeutics (BCAX) United States $0.796B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.790B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.764B 0.00
Tyra Biosciences (TYRA) United States $0.762B 0.00
ArriVent BioPharma (AVBP) United States $0.746B 0.00
LENZ Therapeutics (LENZ) United States $0.718B 0.00
Vir Biotechnology (VIR) United States $0.711B 0.00
Gyre Therapeutics (GYRE) United States $0.707B 146.80
Astria Therapeutics (ATXS) United States $0.701B 0.00
GH Research (GHRS) Ireland $0.698B 0.00
CytomX Therapeutics (CTMX) United States $0.691B 10.48
Geron (GERN) United States $0.689B 0.00
MeiraGTx Holdings (MGTX) United States $0.677B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.669B 0.00
Replimune (REPL) United States $0.663B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $0.661B 0.00
Ventyx Biosciences (VTYX) United States $0.660B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Arvinas (ARVN) United States $0.642B 0.00
Anavex Life Sciences (AVXL) United States $0.636B 0.00
Erasca (ERAS) United States $0.635B 0.00
Myriad Genetics (MYGN) United States $0.590B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.584B 0.00
Opthea (OPT) Australia $0.583B 0.00
Inventiva S.A (IVA) France $0.582B 0.00
Cytek Biosciences (CTKB) United States $0.581B 0.00
REGENXBIO (RGNX) United States $0.564B 0.00
Prime Medicine (PRME) United States $0.563B 0.00
Olema Pharmaceuticals (OLMA) United States $0.562B 0.00
Compass Therapeutics (CMPX) United States $0.553B 0.00
Prothena (PRTA) Ireland $0.543B 0.00
Emergent Biosolutions (EBS) United States $0.539B 5.19
Absci (ABSI) United States $0.537B 0.00
Gossamer Bio (GOSS) United States $0.535B 0.00
Verastem (VSTM) United States $0.530B 0.00
Niagen Bioscience (NAGE) United States $0.527B 41.25
Lexicon Pharmaceuticals (LXRX) United States $0.520B 0.00
Eton Pharmaceuticals (ETON) United States $0.513B 0.00
Monopar Therapeutics (MNPR) United States $0.498B 0.00
Keros Therapeutics (KROS) United States $0.493B 10.50
Alumis (ALMS) United States $0.491B 0.00
NovaBridge Biosciences (NBP) United States $0.483B 0.00
Rapt Therapeutics (RAPT) United States $0.480B 0.00
DBV Technologies S.A (DBVT) France $0.475B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.468B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.451B 0.00
Cullinan Therapeutics (CGEM) United States $0.434B 0.00
Ocugen (OCGN) United States $0.431B 0.00
Neumora Therapeutics (NMRA) United States $0.418B 0.00
PureTech Health (PRTC) United States $0.417B 0.00
Fulcrum Therapeutics (FULC) United States $0.414B 0.00
XOMA Royalty (XOMA) United States $0.412B 0.00
Bright Minds Biosciences (DRUG) United States $0.395B 0.00
Design Therapeutics (DSGN) United States $0.391B 0.00
Kamada (KMDA) Israel $0.381B 19.47
Neurogene (NGNE) United States $0.380B 0.00
Northwest Biotherapeutics (NWBO) United States $0.363B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.362B 0.00
Tectonic Therapeutic (TECX) United States $0.355B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.349B 0.00
LB Pharmaceuticals Inc (LBRX) United States $0.348B 0.00
AC Immune (ACIU) Switzerland $0.346B 0.00
Aura Biosciences (AURA) United States $0.336B 0.00
Annexon (ANNX) United States $0.332B 0.00
Invivyd (IVVD) United States $0.330B 0.00
Solid Biosciences (SLDB) United States $0.328B 0.00
Amarin (AMRN) Ireland $0.324B 0.00
DiaMedica Therapeutics (DMAC) United States $0.322B 0.00
Benitec Biopharma (BNTC) United States $0.315B 0.00
Contineum Therapeutics (CTNM) United States $0.309B 0.00
EnGene Holdings (ENGN) Canada $0.308B 0.00
Kyverna Therapeutics (KYTX) United States $0.307B 0.00
Alto Neuroscience (ANRO) United States $0.301B 0.00
Jade Biosciences (JBIO) United States $0.292B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.280B 0.00
Immuneering (IMRX) United States $0.275B 0.00
Candel Therapeutics (CADL) United States $0.271B 0.00
BioAge Labs (BIOA) United States $0.268B 0.00
Entrada Therapeutics (TRDA) United States $0.264B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.261B 0.00
Atea Pharmaceuticals (AVIR) United States $0.258B 0.00
Alpha Teknova (TKNO) United States $0.257B 0.00
Crescent Biopharma (CBIO) United States $0.256B 0.00
Sagimet Biosciences (SGMT) United States $0.250B 0.00
Lifecore Biomedical (LFCR) United States $0.248B 0.00
Puma Biotechnology (PBYI) United States $0.247B 6.62
Eledon Pharmaceuticals (ELDN) United States $0.246B 0.00
Prima BioMed (IMMP) Australia $0.243B 0.00
Editas Medicine (EDIT) United States $0.242B 0.00
Voyager Therapeutics (VYGR) United States $0.234B 0.00
Allogene Therapeutics (ALLO) United States $0.233B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.233B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.231B 0.00
Cabaletta Bio (CABA) United States $0.227B 0.00
Black Diamond Therapeutics (BDTX) United States $0.227B 11.06
Zura Bio (ZURA) United States $0.226B 0.00
Foghorn Therapeutics (FHTX) United States $0.226B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.225B 0.00
Adherex Technologies (FENC) United States $0.224B 0.00
Tenaya Therapeutics (TNYA) United States $0.220B 0.00
Adocia (ADOCY) France $0.216B 0.00
Abeona Therapeutics (ABEO) United States $0.215B 4.55
Aardvark Therapeutics (AARD) United States $0.214B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.210B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.208B 0.00
Humacyte (HUMA) United States $0.207B 0.00
SELLAS Life Sciences (SLS) United States $0.203B 0.00
Genelux (GNLX) United States $0.202B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.200B 0.00
Caribou Biosciences (CRBU) United States $0.199B 0.00
GENFIT S.A (GNFT) France $0.198B 0.00
Cartesian Therapeutics (RNAC) United States $0.196B 0.00
Nautilus Biotechnology (NAUT) United States $0.191B 0.00
Molecular Partners AG (MOLN) Switzerland $0.189B 0.00
Codexis (CDXS) United States $0.184B 0.00
Coherus Oncology (CHRS) United States $0.173B 0.00
C4 Therapeutics (CCCC) United States $0.169B 0.00
Innate Pharma S.A (IPHA) France $0.166B 0.00
Rani Therapeutics Holdings (RANI) United States $0.163B 0.00
MaxCyte (MXCT) United States $0.157B 0.00
Cardiff Oncology (CRDF) United States $0.150B 0.00
Elicio Therapeutics (ELTX) United States $0.148B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.147B 0.00
Compugen (CGEN) Israel $0.146B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.146B 0.00
Nuvectis Pharma (NVCT) United States $0.145B 0.00
Actuate Therapeutics (ACTU) United States $0.145B 0.00
Forte Biosciences (FBRX) United States $0.142B 0.00
Entera Bio (ENTX) Israel $0.142B 0.00
Anika Therapeutics (ANIK) United States $0.141B 0.00
Nkarta (NKTX) United States $0.140B 0.00
Sangamo Therapeutics (SGMO) United States $0.139B 0.00
PepGen (PEPG) United States $0.138B 0.00
Spero Therapeutics (SPRO) United States $0.135B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.134B 0.00
Climb Bio (CLYM) United States $0.132B 0.00
Alector (ALEC) United States $0.132B 0.00
Vor Biopharma (VOR) $0.130B 0.00
BioHarvest Sciences (BHST) Canada $0.129B 0.00
Scilex Holding (SCLX) United States $0.129B 0.00
TuHURA Biosciences (HURA) United States $0.126B 0.00
Seres Therapeutics (MCRB) United States $0.125B 0.00
VistaGen Therapeutics (VTGN) United States $0.123B 0.00
Agenus (AGEN) United States $0.122B 0.00
Cognition Therapeutics (CGTX) United States $0.122B 0.00
Seer (SEER) United States $0.122B 0.00
Opus Genetics (IRD) United States $0.122B 0.00
Citius Oncology (CTOR) United States $0.120B 0.00
Fate Therapeutics (FATE) United States $0.120B 0.00
Inovio Pharmaceuticals (INO) United States $0.120B 0.00
Alpha Cognition (ACOG) Canada $0.119B 0.00
Turn Therapeutics (TTRX) United States $0.119B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.115B 0.00
Greenwich LifeSciences (GLSI) United States $0.114B 0.00
EXoZymes (EXOZ) United States $0.113B 0.00
Applied Therapeutics (APLT) United States $0.108B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.103B 0.00
Estrella Immunopharma (ESLA) United States $0.102B 0.00
Instil Bio (TIL) United States $0.101B 0.00
Oncolytics Biotech (ONCY) Canada $0.101B 0.00
VTv Therapeutics (VTVT) United States $0.100B 0.00
Immix Biopharma (IMMX) United States $0.100B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.100B 0.00
Whitehawk Therapeutics (WHWK) United States $0.099B 0.00
OKYO Pharma (OKYO) $0.099B 0.00
Coya Therapeutics (COYA) United States $0.096B 0.00
Starpharma Holdings (SPHRY) Australia $0.096B 0.00
Ovid Therapeutics (OVID) United States $0.095B 0.00
Pliant Therapeutics (PLRX) United States $0.094B 0.00
Shattuck Labs (STTK) United States $0.094B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.094B 0.00
Clene (CLNN) United States $0.093B 0.00
Connect Biopharma Holdings (CNTB) United States $0.093B 0.00
Tevogen Bio Holdings (TVGN) United States $0.092B 0.00
Biomea Fusion (BMEA) United States $0.092B 0.00
23andMe Holding (MEHCQ) United States $0.091B 0.00
Adverum Biotechnologies (ADVM) United States $0.090B 0.00
CAMP4 Therapeutics (CAMP) United States $0.090B 0.00
Kalaris Therapeutics (KLRS) United States $0.088B 0.00
Quince Therapeutics (QNCX) United States $0.085B 0.00
Precision BioSciences (DTIL) United States $0.085B 0.00
Artiva Biotherapeutics (ARTV) United States $0.084B 0.00
Atara Biotherapeutics (ATRA) United States $0.083B 0.00
InflaRx (IFRX) Germany $0.081B 0.00
Sutro Biopharma (STRO) United States $0.080B 0.00
BeyondSpring (BYSI) United States $0.077B 0.00
Adagene (ADAG) China $0.076B 0.00
ATyr Pharma (ATYR) United States $0.075B 0.00
Equillium (EQ) United States $0.075B 0.00
Fortress Biotech (FBIO) United States $0.075B 0.00
XBiotech (XBIT) United States $0.073B 0.00
Repare Therapeutics (RPTX) Canada $0.073B 0.00
Immunic (IMUX) United States $0.069B 0.00
ABVC BioPharma (ABVC) United States $0.069B 0.00
CervoMed (CRVO) United States $0.067B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.067B 0.00
TScan Therapeutics (TCRX) United States $0.066B 0.00
BioStem Technologies (BSEM) $0.065B 3.39
ALX Oncology Holdings (ALXO) United States $0.063B 0.00
MiNK Therapeutics (INKT) United States $0.062B 0.00
Spruce Biosciences (SPRB) United States $0.060B 0.00
Werewolf Therapeutics (HOWL) United States $0.058B 0.00
Adlai Nortye (ANL) Cayman Islands $0.057B 0.00
Adicet Bio (ACET) United States $0.056B 0.00
Cue Biopharma (CUE) United States $0.055B 0.00
Oncobiologics (OTLK) United States $0.052B 0.00
Annovis Bio (ANVS) United States $0.049B 0.00
Barinthus Biotherapeutics (BRNS) United States $0.048B 0.00
Senti Biosciences (SNTI) United States $0.047B 0.00
Skye Bioscience (SKYE) United States $0.047B 0.00
TELA Bio (TELA) United States $0.047B 0.00
Celularity (CELU) United States $0.045B 0.00
Kezar Life Sciences (KZR) United States $0.044B 0.00
Genenta Science S.p.A (GNTA) Italy $0.044B 0.00
Aligos Therapeutics (ALGS) United States $0.044B 0.00
INmune Bio (INMB) United States $0.043B 0.00
Medicus Pharma (MDCX) United States $0.043B 0.00
Xilio Therapeutics (XLO) United States $0.043B 0.00
CalciMedica (CALC) United States $0.043B 0.00
OnKure Therapeutics (OKUR) United States $0.043B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.043B 0.00
Grace Therapeutics (GRCE) Canada $0.042B 0.00
PDS Biotechnology (PDSB) United States $0.042B 0.00
Mersana Therapeutics (MRSN) United States $0.040B 0.00
X4 Pharmaceuticals (XFOR) United States $0.040B 0.00
Elutia (ELUT) United States $0.040B 0.00
Hyperion DeFi (HYPD) United States $0.039B 0.00
BioAtla (BCAB) United States $0.038B 0.00
Tvardi Therapeutics (TVRD) United States $0.037B 0.00
Rein Therapeutics (RNTX) United States $0.036B 0.00
Lantern Pharma (LTRN) United States $0.036B 0.00
Radiopharm Theranostics - (RADX) Australia $0.036B 0.00
Dyadic (DYAI) United States $0.035B 0.00
RenovoRx (RNXT) United States $0.035B 0.00
Generation Bio (GBIO) United States $0.034B 0.00
ImageneBio (IMA) United States $0.034B 0.00
Quantum Biopharma (QNTM) Canada $0.033B 0.00
SAB Biotherapeutics (SABS) United States $0.032B 0.00
Tharimmune (THAR) United States $0.032B 0.00
Tenax Therapeutics (TENX) United States $0.032B 0.00
Alterity Therapeutics - (ATHE) Australia $0.031B 0.00
AN2 Therapeutics (ANTX) United States $0.031B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.030B 0.00
Jasper Therapeutics (JSPR) United States $0.030B 0.00
BioXcel Therapeutics (BTAI) United States $0.029B 0.00
Q32 Bio (QTTB) United States $0.028B 0.00
Boundless Bio (BOLD) United States $0.028B 0.00
IBio (IBIO) United States $0.028B 0.00
Synaptogenix (TAOX) United States $0.028B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.028B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.027B 0.00
Exicure (XCUR) United States $0.027B 0.00
Intensity Therapeutics (INTS) United States $0.027B 0.00
Rallybio (RLYB) United States $0.027B 0.00
Pluri (PLUR) Israel $0.027B 0.00
NextCure (NXTC) United States $0.026B 0.00
Femasys (FEMY) United States $0.025B 0.00
Cadrenal Therapeutics (CVKD) United States $0.025B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.024B 0.00
Dare Bioscience (DARE) United States $0.024B 0.00
Lexaria Bioscience (LEXX) Canada $0.024B 0.00
Moleculin Biotech (MBRX) United States $0.023B 0.00
Aytu BioPharma (AYTU) United States $0.022B 0.00
Clearside Biomedical (CLSD) United States $0.021B 0.00
Promis Neurosciences (PMN) Canada $0.021B 0.00
Passage Bio (PASG) United States $0.021B 0.00
Lisata Therapeutics (LSTA) United States $0.021B 0.00
MetaVia (MTVA) United States $0.021B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.020B 0.00
Cingulate (CING) United States $0.020B 0.00
Synlogic (SYBX) United States $0.019B 0.00
Curis (CRIS) United States $0.018B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.018B 0.00
FibroBiologics (FBLG) United States $0.017B 0.00
Hoth Therapeutics (HOTH) United States $0.017B 0.00
Leap Therapeutics (LPTX) United States $0.017B 0.00
Longeveron (LGVN) United States $0.016B 0.00
Allarity Therapeutics (ALLR) United States $0.016B 0.00
Athira Pharma (ATHA) United States $0.016B 0.00
GeoVax Labs (GOVX) United States $0.015B 0.00
Palisade Bio (PALI) United States $0.015B 0.00
Abpro Holdings (ABP) United States $0.015B 0.00
Apollomics (APLM) United States $0.015B 0.00
Propanc Biopharma Inc (PPCB) Australia $0.014B 0.00
Beyond Air (XAIR) United States $0.014B 0.00
BioCardia (BCDA) United States $0.014B 0.00
Chemomab Therapeutics (CMMB) Israel $0.013B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.013B 0.00
Novogen (KZIA) Australia $0.012B 0.00
Edesa Biotech (EDSA) Canada $0.012B 0.00
Dogwood Therapeutics (DWTX) United States $0.012B 0.00
Sensei Biotherapeutics (SNSE) United States $0.012B 0.00
Biofrontera (BFRI) United States $0.012B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Biorestorative Therapies (BRTX) United States $0.011B 0.00
Cocrystal Pharma (COCP) United States $0.010B 0.00
Gelteq (GELS) Australia $0.010B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.010B 0.00
Imunon (IMNN) United States $0.010B 0.00
Purple Biotech (PPBT) Israel $0.010B 0.00
Advanced Biomed (ADVB) United States $0.010B 0.00
BioAffinity Technologies (BIAF) United States $0.009B 0.00
Bolt Biotherapeutics (BOLT) United States $0.009B 0.00
Mustang Bio (MBIO) United States $0.009B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.009B 0.00
Sunshine Biopharma (SBFM) United States $0.009B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.008B 0.00
Alzamend Neuro (ALZN) United States $0.008B 0.00
Avalon GloboCare (ALBT) United States $0.008B 0.00
Galecto (GLTO) Denmark $0.008B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.008B 0.00
IN8bio (INAB) United States $0.008B 0.00
Mainz Biomed (MYNZ) Germany $0.007B 0.00
Adial Pharmaceuticals (ADIL) United States $0.007B 0.00
HCW Biologics (HCWB) United States $0.007B 0.00
Aprea Therapeutics (APRE) United States $0.007B 0.00
Bionano Genomics (BNGO) United States $0.007B 0.00
BRIACELL THERAP (BCTX) Canada $0.007B 0.00
Silo Pharma (SILO) United States $0.007B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.007B 0.00
Evogene (EVGN) Israel $0.006B 0.00
Ensysce Biosciences (ENSC) United States $0.006B 0.00
GENPREX (GNPX) United States $0.006B 0.00
VivoSim Labs (VIVS) United States $0.006B 0.00
Cyclerion Therapeutics (CYCN) United States $0.006B 0.00
Entero Therapeutics (ENTO) United States $0.006B 0.00
Polyrizon (PLRZ) Israel $0.005B 0.00
Soligenix (SNGX) United States $0.005B 0.00
Pasithea Therapeutics (KTTA) United States $0.005B 0.00
Arcadia Biosciences (RKDA) United States $0.005B 0.00
KALA BIO (KALA) United States $0.005B 0.00
Aptevo Therapeutics (APVO) United States $0.005B 0.00
Psyence Biomedical (PBM) Canada $0.005B 0.00
GRI Bio (GRI) United States $0.004B 0.00
Black Titan (BTTC) United States $0.004B 0.00
Onconetix (ONCO) United States $0.004B 0.00
AquaBounty Technologies (AQB) United States $0.004B 0.00
CNS Pharmaceuticals (CNSP) United States $0.004B 0.00
Atrinsic (PTIX) United States $0.004B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.003B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
Revelation Biosciences (REVB) United States $0.002B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
GT Biopharma (GTBP) United States $0.002B 0.00
Artelo Biosciences (ARTL) United States $0.001B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Cellectis S.A (CLLS) France $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
IO Biotech (IOBT) Denmark $0.000B 0.00
MediciNova (MNOV) United States $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
YD Bio (YDES) $0.000B 0.00